The Drug Development Journey for New Cancer Treatments - Part 2
Offered By: Imperial College London via YouTube
Course Description
Overview
Explore the second part of a 17-minute webinar presented by Professor Nick Turner, a renowned expert in breast cancer research and treatment. Delve into clinical studies on AKT inhibitors as part of the drug development journey for new cancer treatments. Gain insights from Turner's role as Team Leader at the Breast Cancer Now Toby Robins Research Centre and his experience as a Consultant Medical Oncologist at the Royal Marsden Hospital. Learn about cutting-edge research in cancer drug development and its potential impact on patient care. For a comprehensive understanding, view the first part of this presentation available through the provided link. Discover more about this research and related topics by visiting the official website of the Academic Health Science Centre.
Syllabus
The drug development journey for new cancer treatments – Prof. Nick Turner (Part 2 of 2)
Taught by
Imperial College London
Related Courses
Introduction to Breast CancerYale University via Coursera Stratégies diagnostiques des cancers
Paris Diderot University via France Université Numerique Electronic Systems for Cancer Diagnosis
Indian Institute of Science Bangalore via Swayam Molecular Tumor Board 2020-21
University of Barcelona via Coursera ON DEMAND: Yale’s Review of Advances in Oncology Highlights from the ASCO® Annual Meeting 2021
Yale University via Independent